Semmax Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Semmax Financial Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$6.23K	Hold	17	–	–	﹤0.01%	285
2025 Q1	$7.22K	Hold	17	–	–	﹤0.01%	257
2024 Q4	$7.86K	Hold	17	–	–	﹤0.01%	239
2024 Q3	$8.33K	Hold	17	–	–	﹤0.01%	229
2024 Q2	$7.95K	Hold	17	–	–	﹤0.01%	248
2024 Q1	$7.31K	Sell	17 -3	-15%	-$1.27K	﹤0.01%	229
2023 Q4	$8.32K	Buy	20 +3	+18%	+$1.11K	﹤0.01%	222
2023 Q3	$6.44K	Buy	+17	New	+$5.95K	﹤0.01%	215
2022 Q4	$5K	Hold	17	–	–	﹤0.01%	205
2022 Q3	$5K	Hold	17	–	–	﹤0.01%	195
2022 Q2	$5K	Hold	17	–	–	﹤0.01%	195
2022 Q1	$4K	Hold	17	–	–	﹤0.01%	227
2021 Q4	$4K	Hold	17	–	–	﹤0.01%	216
2021 Q3	$3K	Hold	17	–	–	﹤0.01%	215
2021 Q2	$3K	Hold	17	–	–	﹤0.01%	212
2021 Q1	$4K	Hold	17	–	–	﹤0.01%	220
2020 Q4	$4K	Hold	17	–	–	﹤0.01%	191
2020 Q3	$5K	Hold	17	–	–	﹤0.01%	175
2020 Q2	$5K	Hold	17	–	–	﹤0.01%	191
2020 Q1	$4K	Hold	17	–	–	﹤0.01%	199
2019 Q4	$4K	Hold	17	–	–	﹤0.01%	231
2019 Q3	$3K	Hold	17	–	–	﹤0.01%	242
2019 Q2	$3K	Hold	17	–	–	﹤0.01%	271
2019 Q1	$3K	Hold	17	–	–	﹤0.01%	405
2018 Q4	$3K	Buy	+17	New	+$2.95K	﹤0.01%	383

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Semmax Financial Advisors's VRTX Position: Q2 2025 in Review

Semmax Financial Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2025 at 17 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Semmax Financial Advisors first reported a position in VRTX in Q4 2018 and has held it in 25 quarters since. The position peaked at $8.33K in Q3 2024. 1,563 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

Semmax Financial Advisors held 17 shares of Vertex Pharmaceuticals worth $6.23K as of Q2 2025.
Semmax Financial Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2025.
Vertex Pharmaceuticals made up ﹤0.01% of Semmax Financial Advisors's portfolio in Q2 2025, its #285 holding.
Semmax Financial Advisors first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 25 quarters since.
Semmax Financial Advisors's Vertex Pharmaceuticals position peaked at $8.33K in Q3 2024.
1,563 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.